Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer
NCT02953860
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Fulvestrant with Enzalutamide
Sponsor
University of Colorado, Denver
Collaborators
[object Object]